Literature DB >> 19336448

Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma.

Kyo Young Song1, Chan Kwon Jung, Won Sang Park, Cho Hyun Park.   

Abstract

OBJECTIVE: This study was designed to determine the level of survivin expression and its clinical significance as a prognostic factor in Stage III gastric adenocarcinoma.
METHODS: We performed immunohistochemical staining for survivin, p53 and Bax in formalin-fixed, paraffin-embedded blocks from 157 surgically resected Stage III gastric cancer tissues. To determine the association with clinical course, we reviewed the patients' clinical records.
RESULTS: Of the 157 gastric cancer tissues, 63 (40.1%) cases showed positive expression for survivin protein. There was no significant association between survivin expression and p53 or Bax. For clinicopathologic parameters, large tumor size was closely related to survivin expression (P < 0.05). The 5-year survival rate of patients with positive survivin expression was significantly lower compared with that for survivin-negative cancer patients (P < 0.05). Survivin and p53 were independent prognostic factors in Stage III gastric cancer.
CONCLUSIONS: Survivin protein is an important predictive and prognostic parameter of poor outcome in gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336448     DOI: 10.1093/jjco/hyp020

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  16 in total

1.  The prognostic significance of p53 expression in gastric cancer: a meta-analysis.

Authors:  Kongkong Wei; Lei Jiang; Yaoyao Wei; Yufeng Wang; Xuankun Qian; Qiang Dai; Quanlin Guan
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-15       Impact factor: 4.553

2.  Role of survivin as prognostic and clinicopathological marker in gastric cancer: a meta-analysis.

Authors:  Andreas Krieg; Billur Baseras; Monika Tomczak; Pablo Emilio Verde; Nikolas Hendrik Stoecklein; Wolfram Trudo Knoefel
Journal:  Mol Biol Rep       Date:  2013-08-15       Impact factor: 2.316

3.  Differentially localized survivin and STAT3 as markers of gastric cancer progression: Association with Helicobacter pylori.

Authors:  Arvind Pandey; Satyendra Chandra Tripathi; Shirish Shukla; Sutapa Mahata; Kanchan Vishnoi; Sri Prakash Misra; Vatsala Misra; Sankar Mitra; Manisha Dwivedi; Alok C Bharti
Journal:  Cancer Rep (Hoboken)       Date:  2018-06-01

4.  Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance.

Authors:  Yu Lei; Zhang Geng; Wu Guo-Jun; Wang He; Yuan Jian-Lin
Journal:  Mol Cell Biochem       Date:  2010-06-19       Impact factor: 3.396

5.  Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer.

Authors:  Hye Sung Won; Myung Ah Lee; Eun-Seon Chung; Dong-Goo Kim; Young Kyoung You; Tae Ho Hong; In-Seok Lee
Journal:  BMC Cancer       Date:  2010-10-19       Impact factor: 4.430

6.  Immunohistochemical expression of nuclear and cytoplasmic survivin in gastrointestinal carcinoma.

Authors:  Michiko Shintani; Akiko Sangawa; Naoki Yamao; Shingo Kamoshida
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

7.  Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas.

Authors:  Levent Dizdar; Monika Tomczak; Thomas A Werner; Sami A Safi; Jasmin C Riemer; Pablo E Verde; Nikolas H Stoecklein; Wolfram T Knoefel; Andreas Krieg
Journal:  Oncol Lett       Date:  2017-09-19       Impact factor: 2.967

8.  Survivin expression in patients with newly diagnosed nodal diffuse large B cell lymphoma (DLBCL).

Authors:  O Markovic; D Marisavljevic; V Cemerikic-Martinovic; T Martinovic; B Filipovic; D Stanisavljevic; R Zivković; J Hajder; N Stanisavljevic; B Mihaljevic
Journal:  Med Oncol       Date:  2012-04-13       Impact factor: 3.064

9.  Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells.

Authors:  Yan-Fang Tao; Jun Lu; Xiao-Juan Du; Li-Chao Sun; Xuan Zhao; Liang Peng; Lan Cao; Pei-Fang Xiao; Li Pang; Dong Wu; Na Wang; Xing Feng; Yan-Hong Li; Jian Ni; Jian Wang; Jian Pan
Journal:  BMC Cancer       Date:  2012-12-26       Impact factor: 4.638

Review 10.  Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.

Authors:  Jin Long Liu; Wei Gao; Qing Min Kang; Xue Jun Zhang; Shu Guang Yang
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.